这是一篇来自已证抗体库的有关
人类 IFNAR1的综述,是根据9篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合IFNAR1 抗体。
IFNAR1 同义词: AVP; IFN-alpha-REC; IFNAR; IFNBR; IFRC; interferon alpha/beta receptor 1; CRF2-1; IFN-R-1; IFN-alpha/beta receptor 1; alpha-type antiviral protein; beta-type antiviral protein; cytokine receptor class-II member 1; cytokine receptor family 2 member 1; interferon (alpha, beta and omega) receptor 1; interferon receptor 1; interferon-alpha/beta receptor alpha chain; interferon-beta receptor 1; type I interferon receptor 1
艾博抗(上海)贸易有限公司
兔 单克隆(EP899Y) | | 艾博抗(上海)贸易有限公司 IFNAR1抗体(Abcam, ab45172)被用于被用于免疫印迹在人类样品上 (图 3f). J Virol (2018) ncbi |
兔 单克隆(EPR6244) | | 艾博抗(上海)贸易有限公司 IFNAR1抗体(Abcam, ab124764)被用于被用于免疫印迹在小鼠样品上浓度为1:25 (图 4b). Proc Natl Acad Sci U S A (2016) ncbi |
兔 单克隆(EP899Y) | | 艾博抗(上海)贸易有限公司 IFNAR1抗体(Abcam, ab45172)被用于被用于抑制或激活实验在人类样品上 (图 7c). Front Microbiol (2015) ncbi |
兔 单克隆(EP899Y) | | 艾博抗(上海)贸易有限公司 IFNAR1抗体(Abcam, ab45172)被用于被用于免疫印迹在人类样品上浓度为1:20000. J Cancer (2013) ncbi |
安迪生物R&D
小鼠 单克隆(85228) | | 安迪生物R&D IFNAR1抗体(R&D, FAB245F)被用于被用于流式细胞仪在人类样品上 (图 1). PLoS ONE (2017) ncbi |
小鼠 单克隆(85228) | | 安迪生物R&D IFNAR1抗体(R&D Systems, FAB245A)被用于被用于流式细胞仪在人类样品上 (图 s3). Eur J Immunol (2016) ncbi |
山羊 多克隆 | | 安迪生物R&D IFNAR1抗体(R&D Systems, AF245)被用于被用于免疫印迹在人类样品上 (图 2). elife (2016) ncbi |
圣克鲁斯生物技术
小鼠 单克隆(H-11) | | 圣克鲁斯生物技术 IFNAR1抗体(Santa Cruz Biotechnology, sc-7391)被用于被用于流式细胞仪在人类样品上 和 被用于免疫印迹在人类样品上. Viral Immunol (2014) ncbi |
小鼠 单克隆(H-11) | | 圣克鲁斯生物技术 IFNAR1抗体(Santa Cruz Biotechnology, sc-7391)被用于被用于免疫印迹在人类样品上浓度为1:200. Cell Death Dis (2014) ncbi |
Xu W, Ma C, Zhang Q, Zhao R, Hu D, Zhang X,
et al. PJA1 Coordinates with the SMC5/6 Complex to Restrict DNA Viruses and Episomal Genes through Interferon-independent Manner. J Virol. 2018;:
pubmed 出版商
Hurtado Guerrero I, Pinto Medel M, Urbaneja P, Rodriguez Bada J, Leon A, Guerrero M,
et al. Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß. PLoS ONE. 2017;12:e0170031
pubmed 出版商
Fuchs S, Kaiser Labusch P, Bank J, Ammann S, Kolb Kokocinski A, Edelbusch C,
et al. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses. Eur J Immunol. 2016;46:2639-2649
pubmed 出版商
Sullivan K, Lewis H, Hill A, Pandey A, Jackson L, Cabral J,
et al. Trisomy 21 consistently activates the interferon response. elife. 2016;5:
pubmed 出版商
Teijaro J, Studer S, Leaf N, Kiosses W, Nguyen N, Matsuki K,
et al. S1PR1-mediated IFNAR1 degradation modulates plasmacytoid dendritic cell interferon-α autoamplification. Proc Natl Acad Sci U S A. 2016;113:1351-6
pubmed 出版商
Tian J, Zhang X, Wu H, Liu C, Li Z, Hu X,
et al. Blocking the PI3K/AKT pathway enhances mammalian reovirus replication by repressing IFN-stimulated genes. Front Microbiol. 2015;6:886
pubmed 出版商
Liu Y, Zhang Z, Zhao X, Yu R, Zhang X, Wu S,
et al. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Viral Immunol. 2014;27:267-76
pubmed 出版商
Mathieu M, Miles A, Ahmad M, Buczek M, Pockley A, Rees R,
et al. The helicase HAGE prevents interferon-?-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death Dis. 2014;5:e1061
pubmed 出版商
Nokes B, Cunliffe H, Lafleur B, Mount D, Livingston R, Futscher B,
et al. In Vitro Assessment of the Inflammatory Breast Cancer Cell Line SUM 149: Discovery of 2 Single Nucleotide Polymorphisms in the RNase L Gene. J Cancer. 2013;4:104-16
pubmed 出版商